ANSELL LIMITED — Earnings Release 2009

Aug 16, 2009

Appendix 4E

Preliminary Final Report For the year ended 30 June 2009

Ansell Limited and Subsidiaries

ACN 004 085 330

Appendix 4E - Page 1

Appendix 4E

Preliminary Final Report

For the year ended 30 June 2009

Ansell Limited and Subsidiaries

ACN 004 085 330

Results for Announcement to the Market

Results for Announcement to the Market
		%		$M
Revenue from ordinary activities	up/(down)	8.5%	to	1,360.6
Profit from ordinary activities after tax
attributable to members	up/(down)	18.3%	to	121.4
Net profit for the period attributable to members	up/(down)	18.3%	to	121.4
Dividends (distributions)	Amount per share	Franked amount		per
			share
Dividend	16.0 ¢		Nil
Record date for determining entitlements to the dividend	31 August 2009

• Sales of $1,352.1 million compared to last year's $1,244.7 million.

• Net profit attributable to members $121.4 million compared to last year's $102.6 million

• Earnings per share of 89.2¢ compared to last year's 73.9¢ .

• A dividend of 16¢ per share unfranked has been declared payable on 23rd September, 2009.

Appendix 4E - Page 2

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

Commentary on Results

(This commentary is in US dollars which is the predominant global currency of Ansell’s business transactions)

Business Review

Profit Attributable of US$90.2 million was a reduction of 1.6% on the previous year’s US$91.7 million.

Reported EPS was US66.3¢, up 0.3% on the previous year’s US66.1¢.

Ansell’s Board has declared a final dividend of A16.0¢ per share unfranked, payable on 23 September, 2009. The financial year dividend declared will therefore be A28.0¢, up 5.7% on the prior year’s A26.5¢.

In the first half, 399,154 shares were bought back under the previous program. No shares have been purchased under the new 2.5 million program announced in April.

Reported results:

eported results:
Reported in Australian Dollars F’08 A$M F’09 A$M % Sales 1,244.7 1,352.1 8.6 EBIT 123.5 142.4 15.3 Profit Attributable 102.6 121.4 18.3 Earnings Per Share (¢) 73.9 89.2 20.7 Dividend 26.5¢ 28.0¢ 5.7	Reported in Operating Currency – US Dollars
	F’08 US$M F’09 US$M %
	1,116.0 1,002.9 -10.1 111.1 107.3 -3.4 91.7 90.2 -1.6 66.1 66.3 +0.3

Underlying results: Excluding net deferred tax adjustments in both periods and depreciation adjustments in the comparative period.

Underlying in Australian Dollars F’08 A$M F’09 A$M % Sales 1,244.7 1,352.1 8.6 EBIT 130.7 142.4 9.0 Profit Attributable 100.7 111.1 10.3 Earnings Per Share (¢) 72.6 81.6 12.4 Dividend 26.5¢ 28.0¢ 5.7	Underlying in Operating Currency – US Dollars
	F’08 US$M F’09 US$M %
	1,116.0 1,002.9 -10.1 117.4 107.3 -8.6 90.8 83.3 -8.3 65.4 61.2 -6.4

Australian dollar results were favourably impacted by a weaker Australian dollar over much of F’09.

Appendix 4E – Page 3

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

Occupational Healthcare:

	A$M	A$M	US$M	US$M
	F’08	F’09	F’08	F’09
Sales Segment EBIT EBIT/Sales	610.6 88.3 14.5%	641.4 69.4 10.8%	547.7 79.3 14.5%	477.4 53.6 11.2%

Occupational accounted for 48% of Revenue and 47% of Segment EBIT.

The global downturn has hit this business sharply with sales falling 16.2%, after excluding the sales from the newly acquired Hawkeye business of US$18 million.

US$ EBIT was down 32.4% as stepped up rationalisation of manufacturing could not offset lost sales, an adverse product mix and the negative impact of lower production on plant overhead recovery. Lower raw material and energy prices helped margins, but reduced production volumes delayed the realisation of these benefits.

Some of the demand reduction was due to de-stocking (by distributors and customers) and appears to have run its course. However, Ansell believes part of this large downward shift in global Occupational demand will be medium-term in nature and action was taken to reduce costs. These included the closure of the Redditch (UK) factory, and reduction of headcount at other sites.

Resources have also been redeployed into new channels. For example, Ansell has developed a “Hand Protection Center” concept for DIY sales through Menard’s stores in the US, which included the release of a synthetic construction glove 3 times more cut resistant than leather. The Hawkeye acquisition has enabled Ansell to access military contracts in the US and opportunities are now being sought abroad.

During the year, Ansell was also proud to receive a prestigious award from Frost & Sullivan in Europe for its Guardian[®] program - our proprietary software tool that assesses hand protection requirements and recommends solutions.

Appendix 4E – Page 4

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

Professional Healthcare:

	A$M	A$M	US$M	US$M
	F’08	F’09	F’08	F’09
Sales Segment EBIT EBIT/Sales	397.7 29.3 7.5%	450.2 55.0 12.1%	356.6 26.6 7.5%	332.2 40.3 12.1%

Professional accounted for 33% of Revenue and 35% of Segment EBIT.

As a result of ongoing product rationalisation in the Americas, global exam glove volumes fell by 16%. Surgical glove volumes were flat overall, with solid growth in the Europe, Middle East and Africa region, and product mix improved as growth in higher end synthetics and powder free gloves was offset by a decline in powdered gloves. The decline in total revenue is due to the planned reduction in exam volumes and to currency translation.

US$ EBIT was up sharply due primarily to lower input costs in addition to a better product mix. Even after the depreciation adjustment is added back to last year’s EBIT – the increase was 26.7% while the current year’s EBIT/sales margin rose above 12%.

Ansell’s strong surgical range, including the polyisoprene and Hydrasoft[®] gloves continues to be at the forefront of the market and we are looking to expand our product portfolio further.

Consumer Healthcare:

	A$M	A$M	US$M	US$M
	F’08	F’09	F’08	F’09
Sales Segment EBIT EBIT/Sales	236.4 19.8 8.3%	260.5 28.5 11.0%	211.7 17.5 8.3%	193.3 21.2 11.0%

Consumer accounted for 19% of Revenue and 18% of Segment EBIT.

US$ Sales were down 8.7%. However, this masked growth in Ansell’s own core branded retail volumes. Strong growth was achieved with the polyisoprene SKYN[TM] condom in the US, Australia performed well and Jissbon’s performance in China (including the launch of our Manix[®] brand) was outstanding. Unimil underperformed, but did better than last year, while substantial ground was conceded due to the loss of our Russian distributor and the stalled Indian Government tender.

US$ EBIT was up 21.1%, due to solid Americas and Jissbon results, lower Unimil losses, and input costs. The EBIT/Sales margin improved to more acceptable levels.

Unused dip lines from Unimil were moved to Thailand and upgraded to be able to produce polyisoprene condoms, thus enabling our very successful SKYN[TM] product to be marketed more widely.

Appendix 4E – Page 5

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

Corporate Business Development:

On 1 July, 2008, the Hawkeye glove business was purchased by Ansell for US$11.6 million, including acquisition costs. Hawkeye is the leading supplier of gloves to the US military and has 5 small US factories.

Hawkeye’s first year with Ansell saw sales recover from a slow start (post acquisition) to end near plan. The business was modestly EPS accretive in its first year of operation and the outlook for the coming year in the US is robust. Ansell is leveraging knowledge and products to seek military glove business outside the US.

Finance:

The weakness of Ansell’s key revenue currencies (Euro, CAD, and AUD) versus the US dollar reduced sales value by approximately 5%. These currencies devalued by 11%-16%, while cost currencies (MYR, THB, LKR, MXN) only fell 2%-9%. However as Ansell did not have sufficient second half hedges in place FX translation negatively impacted full year EBIT.

After a difficult November and December, during which Occupational inventory grew significantly, a focussed second half effort saw inventory return to acceptable levels. Receivables have been tightly controlled all year and the decline in trade creditors is linked to lower purchases. Overall working capital reduced by US$25 million year on year, after excluding the impact of the Hawkeye acquisition. Actual working capital days at the end of June therefore ended unchanged from last year.

Following several years of increases, capital expenditure declined in the current year as Ansell has spare capacity for most of its key manufactured products. Lower taxes were a function of lower profits in the US and Europe – both significantly impacted by recession and FX movements. With lower working capital, capital expenditure and tax payments, free cash flow rose 52% from US$79.8 million to US$121.5 million.

The balance sheet strengthened with gearing of only 16.7% compared to last year’s 20.3%. Interest cover of 13.5 times and EBITDA to net debt of 0.7 times, leave Ansell well placed for the future. Liquidity is also robust with over US$215 million of cash and unused bank facilities of US$70 million at the year end. During the year, a US$50 million facility maturing on 30 April, 2010 was rolled to 30 April, 2012. The remaining US$100 million of debt maturing on 30 April, 2010 can be renewed or repaid with cash.

Early in the year, 399,154 shares were bought back, providing shareholders with A$3.8 million cash, in addition to dividend payments totalling A$37.5 million for the year.

Appendix 4E – Page 6

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Income Statement

of Ansell Limited and Subsidiaries for the year ended 30 June 2009

		2009	2008	2009	2008
	Note	A$m	A$m	US$m(a)	US$m(a)
Revenue
Total revenue	1	1,360.6	1,254.4	1,009.2	1,124.2
Expenses
Cost of goods sold		831.6	756.9	614.1	676.8
Distribution		67.7	61.6	50.2	55.2
Selling, general and administration		310.4	302.7	231.3	272.9
Total expenses, excluding financing costs		1,209.7	1,121.2	895.6	1,004.9
Financing costs		21.2	20.0	15.6	17.4
Profit before income tax		129.7	113.2	98.0	101.9
Income tax		3.3	7.6	4.1	7.5
Profit for theperiod		126.4	105.6	93.9	94.4
Profit for the period is attributable to:
Ansell Limited shareholders		121.4	102.6	90.2	91.7
Minority interests		5.0	3.0	3.7	2.7
Profit for theperiod		126.4	105.6	93.9	94.4
		cents	cents	cents	cents
Earnings per share is based on profit attributable to Ansell
Limited shareholders
Basic earnings per share	5	89.2	73.9	66.3	66.1
Diluted earnings per share	5	88.0	72.5	65.4	64.8

(a) The Company reports in Australian dollars (A$). The United States dollar (US$) is the predominant global currency of our business transactions. For the convenience of the reader, translation of amounts from Australian dollars to US dollars has been made throughout the Income Statement at the average of the 10.00 am mid buy/sell rate for Australian dollars as quoted by Reuters on the last working day of each month for the 13 month period June 2008 to June 2009.

Appendix 4E - Page 7

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Statement of Recognised Income and Expense

of Ansell Limited and Subsidiaries for the year ended 30 June 2009

of Ansell Limited and Subsidiaries for the year ended 30 June 2009
	2009 2008 A$m A$m
Actuarial loss on defined benefit pension /post retirement health benefit plans Net exchange difference on translation of financial statements of foreign operations Net movement in effective hedges for year Net profit/(loss) recognised directly in equity Net profit for the period Total recognised income and expense for the period Attributable to: Members of Ansell Limited Minority interests Total recognised income and expense for the period	(15.0) (2.1) 25.7 (24.6) (1.4) (3.3)
	9.3 (30.0) 126.4 105.6
	135.7 75.6
	130.7 72.6 5.0 3.0
	135.7 75.6

Appendix 4E - Page 8

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Balance Sheet

of Ansell Limited and Subsidiaries

of Ansell Limited and Subsidiaries
		2009	2008	2009	2008
	Note	A$m	A$m	US$m(a)	US$m(a)
Current Assets
Cash on hand		1.1	1.0	0.9	1.0
Cash at bank and on deposit		267.1	195.0	215.6	187.4
Cash - restricted deposits		4.1	4.6	3.3	4.4
Trade and other receivables		183.0	203.3	147.8	195.4
Inventories		189.2	168.1	152.6	161.5
Other		11.1	10.9	9.1	10.4
Total Current Assets		655.6	582.9	529.3	560.1
Non-Current Assets
Trade and other receivables		22.2	17.3	17.9	16.7
Investments		0.2	-	0.2	-
Property, plant and equipment		176.8	167.9	142.7	161.3
Intangible assets		354.8	314.3	286.5	302.0
Deferred tax assets		102.5	74.1	82.8	71.2
Total Non-Current Assets		656.5	573.6	530.1	551.2
Total Assets		1,312.1	1,156.5	1,059.4	1,111.3
Current Liabilities
Trade and other payables		140.4	160.0	113.3	153.9
Interest-bearing liabilities		145.7	14.4	117.7	13.8
Provisions		38.0	51.9	30.7	49.9
Current tax liabilities		11.0	10.2	8.9	9.8
Total Current Liabilities		335.1	236.5	270.6	227.4
Non-Current Liabilities
Trade and other payables		1.1	0.8	0.9	0.7
Interest-bearing liabilities		249.5	319.4	201.4	306.9
Provisions		25.8	20.0	20.8	19.2
Retirement benefit obligations		26.0	9.8	21.0	9.4
Deferred tax liabilities		35.5	24.0	28.7	23.1
Total Non-Current Liabilities		337.9	374.0	272.8	359.3
Total Liabilities		673.0	610.5	543.4	586.7
Net Assets		639.1	546.0	516.0	524.6
Equity
Issued capital		941.1	944.5	759.8	907.6
Reserves		(27.9)	(55.0)	(22.5)	(52.9)
Accumulated losses	3	(288.7)	(356.2)	(233.1)	(342.3)
Total Equity Attributable to Ansell Limited Shareholders		624.5	533.3	504.2	512.4
Minorityinterests		14.6	12.7	11.8	12.2
Total Equity	4	639.1	546.0	516.0	524.6

(a) The Company reports in Australian dollars (A$). The United States dollar (US$) is the predominant global currency of our business transactions. For the convenience of the reader, translation of amounts from Australian dollars to US dollars has been made throughout the Balance Sheet at the 10.00 am mid buy/sell rate for Australian dollars as quoted by Reuters on Monday 30 June 2009, at US$0.8074 = A$1 (June 2008 US$0.96095 = A$1).

Appendix 4E - Page 9

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Cash Flow Statement

of Ansell Limited and Subsidiaries for the year ended 30 June 2009

	2009	2008	2009	2008
	A$m	A$m	US$m(a)	US$m(a)
Cash flows Related to Operating Activities
Receipts from customers	1,387.3	1,253.4	1,029.0	1,123.3
Payments to suppliers and employees	(1,241.5)	(1,069.7)	(920.8)	(961.7)
Net receipts from customers	145.8	183.7	108.2	161.6
Income taxes paid	(14.4)	(21.2)	(10.5)	(19.1)
Net Cash Provided by Operating Activities	131.4	162.5	97.7	142.5
Cash Flows Related to Investing Activities
Payments for businesses, net of cash acquired	(13.1)	-	(11.7)	-
Payments for property, plant and equipment	(18.2)	(23.9)	(14.0)	(21.4)
Proceeds from sale of plant and equipment	0.8	1.7	0.7	1.5
Net Cash Used in Investing Activities	(30.5)	(22.2)	(25.0)	(19.9)
Cash Flows Related to Financing Activities
Proceeds from borrowings	21.0	-	15.6	-
Repayments of borrowings	(3.5)	(5.7)	(2.6)	(5.0)
Net proceeds from/(repayments of) borrowings	17.5	(5.7)	13.0	(5.0)
Proceeds from issues of shares	0.4	-	0.3	-
Payments for share buy-back	(3.8)	(111.9)	(3.7)	(98.1)
Additional contribution from minority interests	2.4	-	1.9	-
Dividends paid	(45.1)	(39.0)	(33.9)	(34.3)
Interest received	8.2	9.6	6.1	8.6
Interest and borrowing costs paid	(21.0)	(20.2)	(15.6)	(17.9)
Net Cash Used in Financing Activities	(41.4)	(167.2)	(31.9)	(146.7)
Net increase/(decrease) in cash and cash equivalents	59.5	(26.9)	40.8	(24.1)
Cash and cash equivalents at the beginning of the financial year	200.6	236.4	192.8	200.2
Effects of exchange rate changes on the balances of cash and cash equivalents
held in foreign currencies at the beginning of the financial year	12.2	(8.9)	(13.8)	16.7
Cash and Cash Equivalents at the End of the Financial Year	272.3	200.6	219.8	192.8

(a) The Company reports in Australian dollars (A$). The United States dollar (US$) is the predominant global currency of our business transactions. For the convenience of the reader, translation of amounts from Australian dollars to US dollars has been made throughout the Cash Flow Statement at the average of the 10.00 am mid buy/sell rate for Australian dollars as quoted by Reuters on the last working day of each month for the 13 month period June 2008 to June 2009.

Appendix 4E - Page 10

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [88 x 35] intentionally omitted <==

Business and Regional Segments

of Ansell Limited and Subsidiaries for the year ended 30 June 2009

	2009 2008 2009 2008 A$m A$m US$m US$m Operating Revenue June June (a)	2009 2008 2009 2008 A$m A$m US$m US$m Operating Result June June (a)
Business Segments Occupational Healthcare 641.4 610.6 477.4 547.7 Professional Healthcare 450.2 397.7 332.2 356.6 Consumer Healthcare 260.5 236.4 193.3 211.7 Total Business Segments 1,352.1 1,244.7 1,002.9 1,116.0 Corporate revenue/costs 8.5 9.7 6.3 8.2 Earnings before Net Interest and Income Tax (EBIT) Financing costs net of interest revenue Profit before Income Tax Income tax Profit for the period Minorityinterests		69.4 88.3 53.6 79.3 55.0 29.3 40.3 26.6 28.5 19.8 21.2 17.5
		152.9 137.4 115.1 123.4 (10.5) (13.9) (7.8) (12.3)
		142.4 123.5 107.3 111.1 (12.7) (10.3) (9.3) (9.2)
		129.7 113.2 98.0 101.9 (3.3) (7.6) (4.1) (7.5)
		126.4 105.6 93.9 94.4 (5.0) (3.0) (3.7) (2.7)
Total Consolidated 1,360.6 1,254.4 1,009.2 1,124.2		121.4 102.6 90.2 91.7
Regional Segments Asia Pacific 235.9 209.1 174.6 187.3 Americas 583.8 522.1 432.2 467.4 Europe,Middle East and Africa 532.4 513.5 396.1 461.3		54.8 33.4 40.1 29.9 41.2 45.6 31.8 40.9 56.9 58.4 43.2 52.6
Total Regional Segments 1,352.1 1,244.7 1,002.9 1,116.0		152.9 137.4 115.1 123.4

	June June June (a) June (a) June June June (a) June (a) 2009 2008 2009 2008 2009 2008 2009 2008 A$m A$m US$m US$m A$m A$m US$m US$m Assets Employed Liabilities
Business Segments Occupational Healthcare Professional Healthcare Consumer Healthcare Total Business Segments Corporate assets/liabilities Cash	408.9 381.2 330.1 366.3 102.9 102.0 83.1 98.1 312.3 293.9 252.2 282.4 78.1 70.6 63.1 67.8 229.9 227.8 185.6 218.9 34.5 34.7 27.9 33.3
	951.1 902.9 767.9 867.6 215.5 207.3 174.1 199.2 88.7 53.0 71.7 50.9 457.5 403.2 369.3 387.5 272.3 200.6 219.8 192.8 - - - -
Total Consolidated	1,312.1 1,156.5 1,059.4 1,111.3 673.0 610.5 543.4 586.7
Regional Segments Asia Pacific Americas Europe, Middle East and Africa Goodwill and Brand names	229.4 213.2 185.2 204.9 79.4 69.6 64.1 66.9 216.4 194.0 174.7 186.3 82.2 73.4 66.5 70.5 160.1 189.0 129.3 181.6 53.9 64.3 43.5 61.8 345.2 306.7 278.7 294.8 - - - -
Total Regional Segments	951.1 902.9 767.9 867.6 215.5 207.3 174.1 199.2

(a) The Company reports in Australian dollars (A$). The United States dollar (US$) is the predominant global currency of our business transactions. For the convenience of the reader, translation of amounts from Australian dollars into US dollars for Operating Revenue and Operating Result have been made at the average of the 10.00am mid buy/sell rate for Australian dollars as quoted by Reuters on the last working day of each month for the 13 month period June 2008 to June 2009. Translation of amounts from Australian dollars into US dollars for Assets Employed and Liabilities have been made at the 10.00am mid buy/sell rate for Australian dollars as quoted by Reuters, on Monday 30 June 2009, at US$0.8074 = A$1 (June 2008 US$0.96095 = A$1).

The above Business and Regional Segments report should be read in conjunction with the accompanying Note 7.

Appendix 4E - Page 11

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Additional Financial Information

The Cash Flow Statement required to be reported for statutory purposes provides an analysis of cash flows which have impacted the cash held by the Company and its subsidiaries. The following analysis is based on the Company's internal cash management reporting which focuses on the cash flow generated by the operations and the movement in net interest bearing debt (NIBD).

(a) Cash Flow Analysis (movement in NIBD)

(a) Cash Flow Analysis (movement in NIBD)
	2009 2008 2009 2008 A$m A$m US$m US$ m
EBIT Depreciation/amortisation/asset write-downs Working Capital Reduction/(Increase) - excluding acquisitions Tax Paid Capital Expenditure Net Interest Paid Free Cash Flow Acquisitions Dividends Paid - Ansell Limited shareholders Contributions of equity Share Buy-Back Other (Increase)/Decrease in NIBD	142.4 123.5 107.3 111.1 31.7 34.0 23.2 30.3 (14.5) 17.3 25.0 (11.8) (14.4) (21.2) (10.5) (19.1) (18.2) (23.9) (14.0) (21.4) (12.8) (10.6) (9.5) (9.3)
	114.2 119.1 121.5 79.8 (15.3) - (13.8) - (37.5) (35.0) (28.2) (30.7) 0.4 - 0.3 - (3.8) (111.9) (3.7) (98.1) (47.2) 24.0 (46.3) 30.2
	10.8 (3.8) 29.8 (18.8)

(b) Abridged Balance Sheet

(b) Abridged Balance Sheet
	2009 2008 2009 2008 A$m A$m US$m US$ m
Fixed Assets Intangibles Other Assets/Liabilities Trade Debtors Inventories Trade Creditors Net Operating Assets NIBD (Interest Bearing Liabilities less Cash at Bank and on Deposit) Shareholders' Equity	176.8 167.9 142.7 161.3 354.8 314.3 286.5 302.0 (14.9) (30.8) (11.9) (29.6) 172.5 191.3 139.3 183.8 189.2 168.1 152.6 161.5 (111.2) (126.0) (89.7) (121.1)
	767.2 684.8 619.5 657.9 (128.1) (138.8) (103.5) (133.3)
	639.1 546.0 516.0 524.6

(c) Reconciliation of Statutory Cash Flow Analysis to Management Cash Flow Analysis

	2009 2008 2009 2008 A$m A$m US$m US$ m
EBIT Depreciation/amortisation/asset write-downs Working Capital Reduction/(Increase) - excluding acquisitions Tax Paid Other Net Cash Provided by Operating Activities Capital Expenditure Net Interest Paid Acquisitions Dividends Paid - Ansell Limited shareholders Contributions of equity Share Buy-Back Effect of exchange rate changes on the balances of cash and interest bearing liabilities held in foreign currencies Other (Increase)/Decrease in NIBD	142.4 123.5 107.3 111.1 31.7 34.0 23.2 30.3 (14.5) 17.3 25.0 (11.8) (14.4) (21.2) (10.5) (19.1) (13.8) 8.9 (47.3) 32.0
	131.4 162.5 97.7 142.5 (18.2) (23.9) (14.0) (21.4) (12.8) (10.6) (9.5) (9.3) (15.3) - (13.8) - (37.5) (35.0) (28.2) (30.7) 0.4 - 0.3 - (3.8) (111.9) (3.7) (98.1) (31.7) 17.2 0.2 0.3 (1.7) (2.1) 0.8 (2.1)
	10.8 (3.8) 29.8 (18.8)

Appendix 4E - Page 12

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Notes

1. Total Revenue

1. Total Revenue
	2009	2008
	A$m	A$m
Revenue from the sale of goods	1,352.1	1,244.7
Revenue From Other Operating Activities
Interest Received or Due and Receivable
From others	8.5	9.7
Total revenue from other operating activities	8.5	9.7
Total Revenue	1,360.6	1,254.4

2. Dividends Paid and Declared

	2009 2008 A$m A$m
Dividends Paid A final dividend of 15.5 cents per share unfranked for the year ended 30 June 2008 (June 2007 - 14 cents unfranked) was paid on 24 September 2008 (2007 - 19 September 2007) An interim dividend of 12 cents per share unfranked for the year ended 30 June 2009 (June 2008 - 11 cents unfranked) was paid on 18 March 2009 (2008 - 19 March 2008)	21.1 19.9 16.4 15.1
	37.5 35.0

Dividends Declared

Since the end of the financial year the Directors have declared a final dividend of 16 cents per share unfranked, for the year ended 30 June 2009.

The financial effect of this dividend has not been brought to account in the financial statements for the year ended 30 June 2009 and will be recognised in subsequent financial reports.

3. Accumulated Losses

3. Accumulated Losses
	2009	2008
	A$m	A$m
Accumulated losses at the beginning of the financial year	(356.2)	(421.4)
Transfers to reserves	(1.4)	(0.3)
Net profit attributable to Ansell Limited shareholders	121.4	102.6
Actuarial loss on defined benefit pension /post retirement health benefit plans	(15.0)	(2.1)
Dividends paid during the year	(37.5)	(35.0)
Accumulated losses at the end of the financial year	(288.7)	(356.2)

Appendix 4E - Page 13

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Notes

Notes
4. Total Equity Reconciliation
	2009	2008
	A$m	A$m
Total equity at the beginning of the financial year	546.0	613.6
Total recognised income and expense for the period	135.7	75.6
Transactions with owners as owners:
Contributions of equity	0.4	-
Share buy-back	(3.8)	(111.9)
Share-based payments reserve	1.4	9.3
Dividends:
Ansell Limited shareholders	(37.5)	(35.0)
Outside shareholders	(7.6)	(4.0)
Movement in minority interest (excluding profit for period and dividends)	4.5	(1.6)
Total equity at the end of the financial year	639.1	546.0
Number of shares on issue as at	30 June 2009	30 June 2008
Ordinary shares fully paid	136,161,986	135,851,540
Executive plan shares paid to 5 cents	73,900	78,900
5. Earnings per Share (EPS)

5. Earnings per Share (EPS)
	2009	2008
	cents	cents
Earnings per Ordinary Share
Basic	89.2	73.9
Diluted	88.0	72.5
	2009	2008
	A$m	A$m
Earnings Reconciliation
Profit for the period	126.4	105.6
Profit attributable to minority interests	5.0	3.0
Earnings used in calculation of Basic and Diluted EPS	121.4	102.6
Weighted average number of ordinary shares used as the denominator	No. Shares	No. Shares
Number of ordinary shares for basic earnings per share	136,084,977	138,782,363
Effect of partly paid Executive Plan shares, Options and Performance Share Rights	1,902,157	2,720,945
Number of ordinary shares and potential ordinary shares
for diluted earnings per share	137,987,134	141,503,308

Partly paid Executive Plan shares, Options and Performance Share Rights have been included in diluted earnings per share in accordance with applicable Australian accounting standards.

6. Net Tangible Asset backing

6. Net Tangible Asset backing
	2009	2008
	A$m	A$m
Shareholders' Equity attributable to Ansell Limited shareholders	624.5	533.3
Less Intangible Assets	354.8	314.3
Net Tangible Assets	269.7	219.0
	No. Shares	No. Shares
Total fully paid ordinary shares on issue (millions)	136.2	135.9
Net tangible asset backing per ordinary share	$1.98	$1.61

Appendix 4E - Page 14

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Notes

7. Notes to the Business and Regional Segments Report

(a) Corporate Revenue and Costs

Represents costs of the Statutory Head Office, part of the costs of the Corporate Head Office and non-sales revenue.

(b) Cash

Cash also includes Accufix Pacing Leads restricted deposits.

(c) Income Tax

The Company regularly reviews the current and projected trading performances of operations in jurisdictions where unbooked tax benefits of operating tax losses exist. As a result of recent strong taxable income in Australia and a favourable medium term outlook, a portion of available unbooked Australian operating tax losses was recognised as a deferred tax asset reducing the current year's income tax charge by $10.3 million (US$6.9 million). The previous year's income tax expense was reduced by the recognition of the remaining unbooked U.S. federal tax losses of $28.2 million (US$24.6 million).

The recognition of unbooked tax losses in other jurisidictions is dependant upon achieving a sustainable improvement in the trading operations in such jurisdictions.

(d) Inter-Segment Transactions

Significant inter-segment sales were made by Asia Pacific - A$246.8 million (US$184.3 million) (2008 - A$212.2 million; US$190.2 million) and Americas - A$246.5 million (US$184.2 million) (2008 - A$247.4 million; US$221.7 million). Inter-segment sales are predominantly made at the same prices as sales to major customers. Operating revenue is shown net of inter-segment values. Accordingly, the Operating revenues shown in each segment reflect only the external sales made by that segment.

(e) Business Segments

The Group comprises the following main business segments:

Occupational Healthcare - manufacture and sale of occupational health and safety gloves.

Professional Healthcare - manufacture and sale of medical, surgical and examination gloves for hand barrier protection and infection control.

Consumer Healthcare - manufacture and sale of condoms, household gloves and other personal products.

(f) Regional Segments

The allocation of Operating Revenue and Operating Results reflect the geographical regions in which the products are sold to external customers. Assets Employed are allocated to the geographical regions in which the assets are located.

Asia Pacific - manufacturing facilities in Malaysia, Thailand, India and Sri Lanka and sales activity.

Americas - manufacturing facilities in USA, Mexico and Brazil and significant sales activity.

Europe, Middle East and Africa - manufacturing facility in Germany and significant sales activity.

	2009	2008	2009	2008
	A$m	A$m	US$m	US$m
(g) Business Segments' Capital Expenditure
Occupational Healthcare	5.2	8.0	4.0	7.2
Professional Healthcare	9.0	11.1	6.9	9.9
Consumer Healthcare	4.0	4.7	3.1	4.2
(h) Regional Segments' Capital Expenditure
Asia Pacific	14.9	20.3	11.5	18.2
Americas	2.4	2.3	1.8	2.0
Europe, Middle East and Africa	0.9	1.2	0.7	1.1
(i) Business Segments' Depreciation
Occupational Healthcare*	11.3	10.6	8.3	9.5
Professional Healthcare*	12.6	16.7	9.3	14.9
Consumer Healthcare	6.4	5.6	4.7	5.0
(j) Business Segments' Other Non Cash Expenses
Occupational Healthcare	9.1	9.6	6.8	7.2
Professional Healthcare	1.3	1.9	1.0	1.4
Consumer Healthcare	1.1	1.4	0.8	1.0

*In the previous year the Occupational and Professional businesses were impacted by the reassessment of the estimated useful lives of dip lines (including associated refurbishments and conversions) resulting in a one-off increase in depreciation expense of $1.3 million (US$1.1 million) and $5.9 million (US$5.2 million) respectively.

Appendix 4E - Page 15

Ansell Limited and Subsidiaries Appendix 4E Preliminary Final Report for the year ended 30 June 2009

==> picture [91 x 36] intentionally omitted <==

Compliance statement

• 1 This report has been prepared in accordance with AASB Standards, other AASB authoritative pronouncements and Urgent Issues Group Consensus Views or other standards acceptable to ASX.

• 2 This report, and the accounts upon which the report is based, use the same accounting policies.

• 3 This report does give a true and fair view of the matters disclosed.

• 4 This report is based on accounts which are in the process of being audited.

• 5 The entity has a formally constituted audit committee.

Signed: .................................................................................. Date 17 August, 2009. Company Secretary

Name: C M Cameron

Appendix 4E - Page 16